M. Tobeña

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region

Ana Sebio, Laia Paré, David Páez et al. · Pharmacogenetics and Genomics · 2013 · 53 citations

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype

David Páez, M. Tobeña, Julen Fernández-Plana et al. · British Journal of Cancer · 2018 · 39 citations · Full text

Relevance of <i>CYP3A4*20</i>, <i>UGT1A1*37</i> and <i>UGT1A1*28</i> variants in irinotecan‐induced severe toxicity

Pau Riera, Juliana Salazar, A.C. Virgili Manrique et al. · British Journal of Clinical Pharmacology · 2018 · 24 citations · Full text

Severe Irinotecan-induced Toxicity, Genetic Epidemiology, Molecular Biology +17

EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer

Ana Sebio, Juliana Salazar, David Páez et al. · The Pharmacogenomics Journal · 2014 · 23 citations

Dna Repair Genes, Medicine, Cancer Genomics +7